Your browser doesn't support javascript.
loading
Clinical and non-clinical determinants of cervical cancer mortality: A retrospective cohort study in Lagos, Nigeria.
Ola, Idris Olasunmbo; Okunowo, Adeyemi Adebola; Habeebu, Muhammad Yaqub; Miao Jonasson, Junmei.
Afiliación
  • Ola IO; Global Health Program, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
  • Okunowo AA; Departments of Clinical and Community Service, The Blue-Pink Center for Women's Health, Lagos, Nigeria.
  • Habeebu MY; Department of Obstetrics & Gynaecology, College of Medicine University of Lagos, Lagos, Nigeria.
  • Miao Jonasson J; Department of Obstetrics & Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Front Oncol ; 13: 1105649, 2023.
Article en En | MEDLINE | ID: mdl-36874121
ABSTRACT

Introduction:

Cervical cancer (CCa) is the fourth most frequent and a common cause of cancer mortality in women, the majority of whom live in low- and middle-income countries. Data on CCa mortality and its determinants have been poorly studied in Nigeria, resulting in a paucity of information that can assist patient management and cancer control policy.

Aim:

The purpose of this study was to assess the mortality rate among CCa patients in Nigeria as well as the major factors influencing CCa mortality. Study

design:

Data from the medical records of 343 CCa patients seen at the Lagos University Teaching Hospital and NSIA-LUTH Cancer Center from 2015 to 2021 were used in a retrospective cohort analysis. The hazard ratios (HR) and confidence intervals (CI) associated with the exposure variables and CCa mortality were calculated using Cox proportional hazard regression.

Results:

The CCa mortality rate was 30.5 per 100 women-years after 2.2 years of median follow-up. Clinical factors such as HIV/AIDS (adjusted HR [aHR] 11.9; 95% CI 4.6, 30.4), advanced clinical stage (aHR 2.7; 95% CI 1.5, 4.7), and anemia at presentation (aHR 1.8; 95% CI 1.1, 3.0) were associated with a higher mortality risk, as were non-clinical factors such as age at diagnosis >50 years (aHR 1.4; 95% CI 1.0, 1.9) and family history of CCa (aHR 3.5; 95%CI 1.1, 11.1).

Conclusion:

CCa has a high mortality rate in Nigeria. Incorporating these clinical and non-clinical factors into CCa management and control policies may improve women's outcomes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suecia